BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 11921610)

  • 1. [Experiences with and impact of health technology assessment on the German Standing Committee of physicians and patients].
    Gibis B; Rheinberger P
    Z Arztl Fortbild Qualitatssich; 2002 Feb; 96(2):82-90. PubMed ID: 11921610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reimbursement and importance of hyperbaric oxygenation for diabetic foot ulcers in German publically funded ambulatory health care].
    Gawlik C; Schmacke N; Gibis B; Sander G; Rheinberger P
    Z Arztl Fortbild Qualitatssich; 2001 Nov; 95(10):715-8. PubMed ID: 11778324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comments by the Working Group for Methods of Economic Evaluation in Health Care (AG MEG) to IQWiG's Draft Guidelines "Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System"].
    Krauth C; John J; Aidelsburger P; Brüggenjürgen B; Hansmeier T; Hessel F; Kohlmann T; Moock J; Rothgang H; Schweikert B; Seitz R; Wasem J;
    Gesundheitswesen; 2008 Jun; 70(6):e1-16. PubMed ID: 18661452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The curriculum Health Technology Assessment (HTA)].
    Perleth M; Gerhardus A; Lühmann D; Rüther A;
    Z Arztl Fortbild Qualitatssich; 2006; 100(4):297-302. PubMed ID: 16878799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
    Sayeed SA
    Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quality of health care, accreditation, and health technology assessment in Croatia: role of agency for quality and accreditation in health].
    Mittermayer R; Huić M; Mestrović J
    Acta Med Croatica; 2010 Dec; 64(5):425-34. PubMed ID: 21692267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A short history of health technology assessment in Germany.
    Perleth M; Gibis B; Göhlen B
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():112-9. PubMed ID: 19500440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health technology assessment.
    Papatheofanis FJ
    Q J Nucl Med; 2000 Jun; 44(2):105-11. PubMed ID: 10967621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possibilities and limitations in priority setting in German ambulatory health care].
    Gibis B
    Z Arztl Fortbild Qualitatssich; 2000 Sep; 94(7):603-9. PubMed ID: 11048346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quality assurance in cardiology: Germany].
    Silber S
    Herz; 1996 Oct; 21(5):273-82. PubMed ID: 9011534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is autologous chondrocyte implantation a technology suitable for ambulatory health care?].
    Gibis B; Gawlik C; Sander G; Rheinberger P
    Z Arztl Fortbild Qualitatssich; 2001 Apr; 95(3):219-23. PubMed ID: 11398625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evidence-based medicine and public health law: statutory health insurance].
    Dreher W
    Z Arztl Fortbild Qualitatssich; 2004 Sep; 98(6):489-93. PubMed ID: 15527192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End-user involvement in health technology assessment (HTA) development: a way to increase impact.
    McGregor M; Brophy JM
    Int J Technol Assess Health Care; 2005; 21(2):263-7. PubMed ID: 15921068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of health technology assessment in shaping the benefits package in The Netherlands.
    Stolk EA; de Bont A; van Halteren AR; Bijlmer RJ; Poley MJ
    Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):85-94. PubMed ID: 19371181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations.
    Manchikanti L
    Pain Physician; 2008; 11(2):161-86. PubMed ID: 18354710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Health technology assessment in the international context: where does Germany stand? For the "German Scientific Working Group Technology Assessment for Health care"].
    Bitzer EM; Busse R; Kohlmann T; Lühmann D; Perleth M
    Z Arztl Fortbild Qualitatssich; 1999 Jan; 93(1):33-8. PubMed ID: 10198976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Historical development of health technology assessment in Thailand.
    Teerawattananon Y; Tantivess S; Yothasamut J; Kingkaew P; Chaisiri K
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():241-52. PubMed ID: 19527543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and implementation of health technology assessment in Argentina: two steps forward and one step back.
    Rubinstein A; Pichon-Riviere A; Augustovski F
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():260-9. PubMed ID: 19527545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.